Rockwell Medical
RMTI • NASDAQ
Rockwell Medical is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Mark Strobeck, with a market cap of $34.3M.
CEOMark Strobeck
Market Cap$34.3M
Drug Manufacturers - Specialty & Generic
Healthcare
Employees237.0
Websiterockwellmed.com
Next Earnings
Upcoming earnings announcement for Rockwell Medical
Date
Monday, May 11, 2026 (in a month)
Timing
Before Market Open (6:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.03
Revenue Estimate
$17.8M
Earnings History
Past 12 earnings reports for Rockwell Medical
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 26, 2026 | Q4 2025 | $0.02Est: $0.03 | -33.3% | $18.3MEst: $18.6M | -1.2% |  10-K |
| Nov 12, 2025 | Q3 2025 | $0.00Est: -$0.04 | +100.0% | $15.9MEst: $16.5M | -3.3% | 10-Q |
| Aug 14, 2025 | Q2 2025 | -$0.01Est: -$0.05 | +80.0% | $16.1MEst: $16.1M | -0.5% | 10-Q |
| May 12, 2025 | Q1 2025 | -$0.01Est: -$0.03 | +66.7% | $18.9MEst: $17.8M | +6.3% | 10-Q |
| Mar 20, 2025 | Q4 2024 | $0.04Est: $0.02 | +100.0% | $24.7MEst: $22.6M | +9.1% | 10-K |
| Nov 12, 2024 | Q3 2024 | $0.09Est: $0.01 | +800.0% | $28.3MEst: $26.5M | +6.9% | 10-Q |
| Aug 8, 2024 | Q2 2024 | $0.05Est: -$0.03 | +266.7% | $25.8MEst: $22.9M | +12.7% | 10-Q |
| May 14, 2024 | Q1 2024 | -$0.02Est: -$0.04 | +50.0% | $22.7MEst: $21.7M | +4.5% | 10-Q |
| Mar 21, 2024 | Q4 2023 | $0.02Est: -$0.07 | +128.6% | $22.1MEst: $22.6M | -2.4% | 10-K |
| Nov 14, 2023 | Q3 2023 | -$0.07Est: -$0.10 | +30.0% | $23.8MEst: $22.9M | +4.0% | — |
| Aug 14, 2023 | Q2 2023 | -$0.18Est: -$0.12 | -50.0% | $18.1MEst: $18.1M | 0.0% | 10-Q |
| May 15, 2023 | Q1 2023 | -$0.10Est: -$0.16 | +37.5% | $19.7MEst: $19.1M | +2.9% | — |